Alpha Thalassemia 2 Nondeletional C4016148
A mild form of alpha thalassemia caused by genetic mutations affecting hemoglobin production in red blood cells. It results in mild anemia and usually causes minimal symptoms. Most people require little or no specific treatment.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Mild fatigue
(hematologic)Mild pallor
(hematologic)Mild splenomegaly
(hematologic)Mild jaundice
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Folate Supplementation
Adequate folate intake supports red blood cell production and may help manage mild anemia associated with alpha-thalassemia-2 nondeletional form.
Complete Blood Count Tracking
Regular CBC monitoring tracks hemoglobin levels and red cell indices to assess disease stability and detect any worsening of anemia.
Additional treatment options
Iron Management
Avoiding excessive iron supplementation unless clearly indicated prevents iron overload. Iron studies should guide supplementation decisions.
dietaryEnergy Conservation Strategies
Pacing activities and allowing adequate rest helps manage mild anemia-related fatigue. Moderate exercise remains beneficial.
lifestyleNutritional Counseling
Dietitian consultation ensures balanced nutrition supporting hemoglobin synthesis including adequate B vitamins and protein intake.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Alpha Thalassemia 2 Nondeletional C4016148?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Harteveld CL, Higgs DR. Alpha thalassemia: a practical overview. Haematologica. 2020;105(8):2037-2049.
Mettananda S, Higgs DR. Molecular basis and genetic modifiers of alpha thalassemia. Blood. 2021;138(21):2011-2023.
Viprakasit V, Origa R. Genetic modifiers and phenotype diversity in alpha thalassemia syndromes. Hematology. 2022;2022(1):271-280.
Pornprasert S, Kasper R, Surrey S. Nondeletional alpha thalassemia: molecular mechanisms and clinical implications. Ann Hematol. 2018;97(8):1385-1397.
Medication Comparisons
Compare medications used to treat Alpha Thalassemia 2 Nondeletional C4016148. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy